Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens.

Briefings in bioinformatics·2026
Same author

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

The Journal of pathology·2026
Same author

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational Status.

International journal of molecular sciences·2026
Same author

macpie: Scalable workflow for high-throughput transcriptomic profiling.

Computational and structural biotechnology journal·2025
Same author

Development of a targeted BioPROTAC degrader selective for misfolded SOD1.

Nature communications·2025
Same author

Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.

Molecular cancer therapeutics·2025

Related Experiment Video

Updated: Apr 28, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

10.4K

A high-throughput, multiplex cell death assay using an RNAi screening approach.

Katrina J Falkenberg1, Darren N Saunders2, Kaylene J Simpson3

  • 1Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Department of Pathology, The University of Melbourne, Parkville, Victoria 3052, Australia.

Cold Spring Harbor Protocols
|June 4, 2014
PubMed
Summary

This study introduces a multiplex cell death assay for high-throughput screening. It identifies genes that enhance drug-induced apoptosis, improving drug discovery and cancer research.

More Related Videos

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs
07:27

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs

Published on: August 3, 2011

23.2K
MISSION esiRNA for RNAi Screening in Mammalian Cells
15:31

MISSION esiRNA for RNAi Screening in Mammalian Cells

Published on: May 12, 2010

18.8K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

10.4K
High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs
07:27

High Throughput MicroRNA Profiling: Optimized Multiplex qRT-PCR at Nanoliter Scale on the Fluidigm Dynamic ArrayTM IFCs

Published on: August 3, 2011

23.2K
MISSION esiRNA for RNAi Screening in Mammalian Cells
15:31

MISSION esiRNA for RNAi Screening in Mammalian Cells

Published on: May 12, 2010

18.8K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Drug discovery requires methods to identify synergistic gene targets.
  • Apoptosis assays are crucial for understanding cell death pathways.

Purpose of the Study:

  • To develop and validate a high-throughput, multiplex cell death assay.
  • To identify genes cooperating with drugs to induce apoptosis using a genome-scale siRNA screen.

Main Methods:

  • Utilized the ApoLive-Glo assay measuring cell viability and caspase activity.
  • Employed high-content imaging for control cell viability assessment.
  • Integrated automation and robotic liquid handling for efficiency and reproducibility.

Main Results:

  • The multiplex assay distinguishes rapid cell death from caspase activation.
  • Identified genes essential for viability and those synergistically enhancing drug-induced cell death.
  • Validated candidate targets using flow cytometry.

Conclusions:

  • The developed assay enables efficient identification of synergistic gene targets.
  • This approach accelerates the discovery of novel cancer therapeutics.
  • The protocol enhances reproducibility and throughput in cell death studies.